The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation.
作者信息
Liumbruno Giancarlo Maria, D'Alessandro Angelo, Rea Federica, Piccinini Vanessa, Catalano Liviana, Calizzani Gabriele, Pupella Simonetta, Grazzini Giuliano
机构信息
Centro Nazionale Sangue, Istituto Superiore di Sanità, Roma.
出版信息
Blood Transfus. 2010 Jan;8(1):8-16. doi: 10.2450/2009.0108-09.
Abstract
摘要
相似文献
1
The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation.产前免疫预防在预防母婴抗Rh（D）同种免疫中的作用。
Blood Transfus. 2010 Jan;8(1):8-16. doi: 10.2450/2009.0108-09.
2
[Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].[母婴红细胞不相容性：从孕妇的免疫血液学监测到新生儿溶血病]
Transfus Clin Biol. 2005 Feb;12(1):45-55. doi: 10.1016/j.tracli.2005.02.001.
3
Prevention of haemolytic disease of the newborn by anti-D serum given to the mother.通过给母亲注射抗-D血清预防新生儿溶血病。
Ger Med Mon. 1967 Dec;12(12):570-1.
4
Prevention of Rh haemolytic disease.预防Rh溶血病。
Nurs Mirror Midwives J. 1974 Oct 24;139(17):57-9.
5
[Development and present status of immunoprophylaxis of Rh-sensitization].[Rh致敏免疫预防的发展与现状]
Z Arztl Fortbild (Jena). 1970 Dec 1;64(3):1181-5.
6
[Foetal erythrocytes in maternal blood and immunoprophylaxis of Rh-immunization. Clinical and experimental studies].[母血中的胎儿红细胞与Rh免疫的免疫预防。临床与实验研究]
Acta Obstet Gynecol Scand Suppl. 1972;20:1-128.
7
[Prevention of RH-erythroblastosis by anti-D-application to the mother].通过给母亲应用抗-D预防Rh血型不合溶血病
Monatsschr Kinderheilkd (1902). 1968 Jun;116(6):236-8.
8
[Prevention of Rh sensitization using immunoglobulin anti-D].使用抗D免疫球蛋白预防Rh致敏
Schweiz Med Wochenschr. 1969 Oct 18;99(42):1519-21.
9
Use of different doses of anti-Rh IgG in the prevention of Rh isoimmunisation.使用不同剂量抗Rh免疫球蛋白预防Rh血型同种免疫。
Lancet. 1969 Aug 9;2(7615):288-90. doi: 10.1016/s0140-6736(69)90053-1.
10
[Immunoprophylaxis in serologic incompatibility].[血清不相容性中的免疫预防]
Pediatr Pol. 1973 Jun;48(6):771-7.
引用本文的文献
1
Patient experience and burden of haemolytic disease of the foetus and newborn: a systematic review.胎儿和新生儿溶血病的患者体验与负担：一项系统综述
BMC Pregnancy Childbirth. 2025 Feb 4;25(1):114. doi: 10.1186/s12884-025-07208-9.
2
Red Blood Cell Alloimmunization in Pregnancy: A Review of the Pathophysiology, Prevalence, and Risk Factors.妊娠期红细胞同种免疫：病理生理学、患病率及危险因素综述
Cureus. 2024 May 12;16(5):e60158. doi: 10.7759/cureus.60158. eCollection 2024 May.
3
Maternal red blood cell alloimmunization prevalence in the United States.美国母婴红细胞同种免疫的流行率。
Blood Adv. 2024 Aug 27;8(16):4311-4319. doi: 10.1182/bloodadvances.2023012241.
4
Noninvasive fetal blood group antigen genotyping.非侵入性胎儿血型抗原基因分型
Blood Transfus. 2025 Mar;23(2):101-108. doi: 10.2450/BloodTransfus.712. Epub 2024 Jan 29.
5
Immunohaematological conundrums in obstetrics from transfusion services viewpoint in Armed Forces setup.从武装部队输血服务角度看产科中的免疫血液学难题
Med J Armed Forces India. 2023 May-Jun;79(3):280-285. doi: 10.1016/j.mjafi.2021.05.017. Epub 2021 Aug 13.
6
Upregulation of miR-181a-5p and miR-125b-2-3p in the Maternal Circulation of Fetuses with Rh-Negative Hemolytic Disease of the Fetus and Newborn Could Be Related to Dysfunction of Placental Function.miR-181a-5p 和 miR-125b-2-3p 在 Rh 阴性胎儿和新生儿溶血病胎儿母血中的上调可能与胎盘功能障碍有关。
Dis Markers. 2022 Sep 21;2022:2594091. doi: 10.1155/2022/2594091. eCollection 2022.
7
Fetal-maternal incompatibility in the Rh system. Rh isoimmunization associated with hereditary spherocytosis: case presentation and review of the literature.Rh 系统中的胎儿-母体不相容性。与遗传性球形红细胞增多症相关的 Rh 同种免疫：病例介绍和文献复习。
Rom J Morphol Embryol. 2022 Jan-Mar;63(1):229-235. doi: 10.47162/RJME.63.1.26.
8
Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations.推荐用于验证和质量保证的非侵入性产前测试胎儿血型和对欧盟法规下的体外诊断试剂风险分类的影响。
Vox Sang. 2022 Feb;117(2):157-165. doi: 10.1111/vox.13172. Epub 2021 Jun 21.
9
Educational Case: Anemia in a Neonate.教学案例：新生儿贫血
Acad Pathol. 2021 Apr 8;8:23742895211002829. doi: 10.1177/23742895211002829. eCollection 2021 Jan-Dec.
10
Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚产科人群中恒河猴D阴性血型的患病率及恒河猴D免疫预防的挑战：一项系统评价和荟萃分析。
Matern Health Neonatol Perinatol. 2021 Feb 2;7(1):8. doi: 10.1186/s40748-021-00129-3.
本文引用的文献
1
Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.孕期注射抗-D预防恒河猴血型同种免疫。
Cochrane Database Syst Rev. 2013 Feb 28(2):CD000020. doi: 10.1002/14651858.CD000020.pub2.
2
Implementation of NICE recommendation for a policy of routine antenatal anti-D prophylaxis: a survey of UK maternity units.英国国家卫生与临床优化研究所（NICE）关于常规产前抗-D预防政策建议的实施情况：对英国产科单位的一项调查
Transfus Med. 2008 Oct;18(5):292-5. doi: 10.1111/j.1365-3148.2008.00882.x.
3
Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn.从多年来在人体中使用抗-D预防RhD免疫及胎儿和新生儿溶血病的经验中汲取的教训。
Clin Exp Immunol. 2008 Oct;154(1):1-5. doi: 10.1111/j.1365-2249.2008.03735.x. Epub 2008 Aug 22.
4
The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.从母体血浆中确定胎儿的D状态以决定Rh预防措施是可行的。
Transfusion. 2008 Nov;48(11):2292-301. doi: 10.1111/j.1537-2995.2008.01843.x. Epub 2008 Aug 7.
5
RHD genotyping from maternal plasma: guidelines and technical challenges.从母体血浆中进行RHD基因分型：指南与技术挑战
Methods Mol Biol. 2008;444:185-201. doi: 10.1007/978-1-59745-066-9_14.
6
Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services.将用于红细胞分型和相容性检测的分子技术整合到血液中心和输血服务中。
Transfus Med Rev. 2008 Apr;22(2):117-32. doi: 10.1016/j.tmrv.2007.12.002.
7
An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.RhD阴性患者中与非同种免疫相关的宫内胎儿死亡风险增加。
J Matern Fetal Neonatal Med. 2008 Apr;21(4):255-9. doi: 10.1080/14767050801928804.
8
New technologies to replace current blood typing reagents.用于替代现有血型鉴定试剂的新技术。
Curr Opin Hematol. 2007 Nov;14(6):677-81. doi: 10.1097/MOH.0b013e3282ef1838.
9
Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers.RhD单克隆抗体在临床试验中作为预防性抗-D免疫球蛋白替代疗法的疗效：问题多于答案。
Vox Sang. 2007 Aug;93(2):99-111. doi: 10.1111/j.1423-0410.2007.00945.x.
10
Blood group genotyping in Germany.德国的血型基因分型
Transfusion. 2007 Jul;47(1 Suppl):47S-53S. doi: 10.1111/j.1537-2995.2007.01310.x.
Zotero 插件